Bayer/GSK vardenafil
Executive Summary
Trade name for erectile dysfunction disorder drug vardenafil is Levitra, Bayer and GlaxoSmithKline announce. Bayer had earlier referred to the drug as Nuviva; the name was one of several submitted to FDA for approval (1"The Pink Sheet" March 18, p. 29). The companies received an "approvable" letter for vardenafil in July; approval is expected in 2003 (2"The Pink Sheet" July 29, In Brief)...
You may also be interested in...
Analysts Presentations, Conference Calls In Brief
Bayer's vardenafil is Nuviva: Bayer's brand name for vardenafil is Nuviva, R&D Board Committee Chair Frank Morich, PhD, announced during a press briefing March 13. An NDA for the erectile dysfunction drug is pending at FDA; Bayer expects approval in the second half of 2002. Nuviva will be co-promoted with GlaxoSmithKline...
At-Home Health Testing Demand Is High Post-Pandemic, But So Are Barriers To Development And Use
At the recent Precision Med-Tri Con conference, laboratory experts traded views on the expansion of at-home testing for disease diagnosis and personalized health insights. While strong consumer demand spells opportunity, there are significant concerns about the accuracy and reliability of home-testing platforms, misuse, accessibility, and lack of health literacy.
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.